About Protein FAM117A
Protein FAM117A (FAM117A) is a protein
from Homo sapiens identified by UniProt accession
Q9C073, 453 residues long.
MolForge cross-references it against 0 known binders and
28 disease associations.
Target properties
| Protein name | Protein FAM117A |
| UniProt accession | Q9C073 |
| Gene | FAM117A |
| Organism | Homo sapiens |
| Length | 453 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (28)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.42
- mean corpuscular hemoglobin · score 0.40
- Red cell distribution width · score 0.39
- serum albumin measurement · score 0.35
- mean reticulocyte volume · score 0.30
- calcium measurement · score 0.30
- erythrocyte count · score 0.29
- total blood protein measurement · score 0.29
- neurodegenerative disease · score 0.28
- alkaline phosphatase measurement · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9C073-F1 | alphafold | PREDICTED | 55.52 | — |
Amino-acid sequence (453 residues)
MAGAAAGGRG GGAWGPGRGG AGGLRRGCSP PAPAGSPRAG LQPLRATIPF QLQQPHQRRD GGGRAASVPC SVAPEKSVCR PQPLQVRRTF SLDTILSSYL LGQWPRDADG AFTCCTNDKA TQTPLSWQEL EGERASSCAH KRSASWGSTD HRKEISKLKQ QLQRTKLSRS GKEKERGSPL LGDHAVRGAL RASPPSFPSG SPVLRLSPCL HRSLEGLNQE LEEVFVKEQG EEELLRILDI PDGHRAPAPP QSGSCDHPLL LLEPGNLASS PSMSLASPQP CGLASHEEHR GAAEELASTP NDKASSPGHP AFLEDGSPSP VLAFAASPRP NHSYIFKREP PEGCEKVRVF EEATSPGPDL AFLTSCPDKN KVHFNPTGSA FCPVNLMKPL FPGMGFIFRN CPSNPGSPLP PASPRPPPRK DPEASKASPL PFEPWQRTPP SEEPVLFQSS LMV
Explore Protein FAM117A with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets